Category: Bruker Corp.
ConMed closes its 27¢-per-share tender offer for medical imaging company Viking Systems, giving it about 84% of Viking as it looks to close its short-form merger.
ConMed (NSDQ:CNMD) said it's closed its 27¢-per-share tender offer for Viking Systems (OTC:VKNG), leaving it with about 84% of shares in the medical imaging maker.
Shares of Bruker Corp. are down nearly 12% today after the medical device company cut its earnings forecast in half.
Bruker Corp. (NSDQ:BRKR) shares took a double-digit dive this morning after the medical device company said it expects the European fiscal crisis to cut its 2ns-quarter per-share earnings roughly in half.
Bruker said it expects to report adjusted EPS of 11¢-13¢ for the 3 months ended June 30, on sales of about $420 million. Wall Street analysts were expecting adjusted EPS of 21¢.
Boston Scientific launches its BackStop kidney stone treatment, licensed from Pluromed, in the U.S. and certain international markets; also, Siemens lands 3rd year defense contract worth up to $1.9 billion; Bruker Corp. nabs all shares of SkyScan for an undisclosed amount; Viking expects 40% sales growth for Q1 2012; Smith & Nephew acquires LifeModeler for an undisclosed amount; Wound Care Innovations signs exclusive N.A.
Boston Scientific (NYSE:BSX) launched its BackStop kidney stone treatment product in the U.S. and certain international markets this week.
Could the installation of Johnson & Johnson's top medical device exec as bitter rival Boston Scientific's new CEO could signal the conglomerate's interest in acquiring BSX?; also, Integra to pay $65 million for Ascension Orthopedics; Solta Medical buys LipoSonix from Medicis for $15 million; Vasomedical buys Chinese suppliers; Hill-Rom pays $20 million for French, Swiss distributors; Bruker to buy CETR; Elekta closes Nucletron deal; and DGT Holdings deals Italian subsidiary to VIV for $22.5 million.
Could the amicable deal between bitter rivals Johnson & Johnson (NYSE:JNJ) and Boston Scientific (NYSE:BSX) over Michael Mahoney leaving J&J to helm BSX signal an upcoming acquisition?
Opinions are divided on Wall Street, with at least one analyst wondering if a deal could be in the works and others casting doubt on the speculation.
BILLERICA, Mass.--(BUSINESS WIRE)--Bruker Corporation today announced the signing of a purchase agreement
to acquire Center for Tribology, Inc. (CETR) for an undisclosed amount.
CETR, a privately held corporation located in Silicon Valley in
Campbell, CA, is projected to have calendar year 2011 revenue greater
than $10 million and EBITDA greater than $2 million. The transaction is
expected to close at the end of the third quarter of 2011, subject to
customary closing conditions. After the closing, Bruker intends to
continue to operate CETR in Silicon Valley and to integrate its business
management, operations, research and development, sales and support with
Chemical engineering professor Bob Langer wins 2011 Warren Alpert Foundation Prize for bioengineering pioneers for his work in drug delivery and tissue engineering.
Bob Langer, MIT professor and bioengineering hot-shot, was chosen to recieve the 2011 Alpert Prize for his advancements in drug delivery and tissue engineering.